- Home
- ALVO vs ASB Comparison
ALVO vs ASB Comparison
Compare ALVO & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- ASB
- Stock Information
- Founded
- ALVO 2013
- ASB 1861
- Country
- ALVO Luxembourg
- ASB United States
- Employees
- ALVO N/A
- ASB N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- ALVO Health Care
- ASB Finance
- Exchange
- ALVO Nasdaq
- ASB Nasdaq
- Market Cap
- ALVO 3.4B
- ASB 3.6B
- IPO Year
- ALVO N/A
- ASB N/A
- Fundamental
- Price
- ALVO $12.60
- ASB $24.51
- Analyst Decision
- ALVO Buy
- ASB Hold
- Analyst Count
- ALVO 1
- ASB 9
- Target Price
- ALVO $18.00
- ASB $26.11
- AVG Volume (30 Days)
- ALVO 145.6K
- ASB 1.5M
- Earning Date
- ALVO 11-13-2024
- ASB 01-23-2025
- Dividend Yield
- ALVO N/A
- ASB 3.80%
- EPS Growth
- ALVO N/A
- ASB N/A
- EPS
- ALVO N/A
- ASB 1.20
- Revenue
- ALVO $393,919,000.00
- ASB $1,007,710,000.00
- Revenue This Year
- ALVO $398.12
- ASB N/A
- Revenue Next Year
- ALVO $44.73
- ASB $17.50
- P/E Ratio
- ALVO N/A
- ASB $20.28
- Revenue Growth
- ALVO 517.92
- ASB N/A
- 52 Week Low
- ALVO $9.15
- ASB $19.40
- 52 Week High
- ALVO $18.00
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- ALVO 63.60
- ASB 41.87
- Support Level
- ALVO $11.70
- ASB $23.44
- Resistance Level
- ALVO $12.25
- ASB $26.62
- Average True Range (ATR)
- ALVO 0.28
- ASB 0.71
- MACD
- ALVO 0.13
- ASB -0.22
- Stochastic Oscillator
- ALVO 94.28
- ASB 33.65
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.